Hsbc Holdings PLC Novartis Ag Transaction History

Hsbc Holdings PLC

$168 Billion
Q3 2024

A detailed history of Hsbc Holdings PLC transactions in Novartis Ag stock. As of the latest transaction made, Hsbc Holdings PLC holds 100,904 shares of NVS stock, worth $9.87 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

100,904

Previous 214,962 53.06%

Holding current value

$9.87 Million

Previous $22.9 Million 49.29%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$106.13 - $120.89 $12.1 Million - $13.8 Million	-114,058 Reduced 53.06%	100,904 $11.6 Million
Q2 2024 Aug 12, 2024	BUY	$92.57 - $107.37 $19.9 Million - $23.1 Million	214,962 New	214,962 $22.9 Million
Q4 2022 Feb 14, 2023	BUY	$75.55 - $92.52 $5.54 Million - $6.79 Million	73,350 New	73,350 $6.65 Million
Q4 2021 Feb 11, 2022	SELL	$79.7 - $88.13 $435,002 - $481,013	-5,458 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$81.78 - $95.14 $446,355 - $519,274	5,458 New	5,458 $446,000
Q2 2019 Aug 13, 2019	SELL	$75.4 - $92.8 $196,643 - $242,022	-2,608 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$75.32 - $86.15 $196,434 - $224,679	2,608 New	2,608 $251,000
Q2 2018 Aug 10, 2018	SELL	$64.91 - $73.36 $178,956 - $202,253	-2,757 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$70.39 - $84.15 $153,027 - $182,942	-2,174 Reduced 44.09%	2,757 $223,000
Q4 2017 Feb 14, 2018	BUY	$72.33 - $77.64 $82,022 - $88,043	1,134 Added 29.87%	4,931 $414,000
Q3 2017 Nov 14, 2017	SELL	$74.14 - $77.27 $11,565 - $12,054	-156 Reduced 3.95%	3,797 $326,000
Q2 2017 Aug 14, 2017	BUY	N/A	3,953	3,953 $330,000

Others Institutions Holding NVS

# of Institutions

1,438

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $210B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Novartis Ag Transaction History